Citation Impact
Citing Papers
Increasing homogeneity in global food supplies and the implications for food security
2014 Standout
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
2015
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml
1997
Molecular imaging in drug development
2008 Standout
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Conformal proton therapy for prostate carcinoma
1998
Ongoing Care of Patients After Primary Treatment for Their Cancer
2003
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Physical activity and sexual functioning after radiotherapy for prostate cancer: Beneficial effects for patients undergoing external beam radiotherapy
2005
Nomograms in oncology: more than meets the eye
2015 Standout
Head and neck cancer
2008 Standout
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Hepatocellular carcinoma
2021 Standout
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy
2003
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 gy)
2002
An assessment of the global impact of 21st century land use change on soil erosion
2017 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Aptamers as therapeutics
2010 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer
1999
Is it time to consider a role for MRI before prostate biopsy?
2009
External beam radiation therapy for prostate cancer
2000
Perineural Invasion is a Marker for Pathologically Advanced Disease in Localized Prostate Cancer
2007
Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial
1997
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
1998
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Cumulative Deficits Better Characterize Susceptibility to Death in Elderly People than Phenotypic Frailty: Lessons from the Cardiovascular Health Study
2008
Gene expression correlates of clinical prostate cancer behavior
2002 Standout
Diabetes mellitus: a predictor for late radiation morbidity
1999
Radiotherapy: what can be achieved by technical improvements in dose delivery?
2005
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
1996 Standout
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates
2011
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Frailty in elderly people
2013 Standout
Hepatocellular carcinoma
2022 Standout
Head and Neck Cancer
2001 Standout
Perineural invasion in cancer
2009 Standout
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
Age-Related Prostate Cancer Metastases
1998
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Crop Species Diversity Affects Productivity and Weed Suppression in Perennial Polycultures under Two Management Strategies
2008
THE RELATIVE IMPACT AND FUTURE BURDEN OF PROSTATE CANCER IN THE UNITED STATES
2004
ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
2001
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage
2017
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer
2000
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer
2005
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
2010
PROSTATE SPECIFIC ANTIGEN DOUBLING TIME AS A SURROGATE END POINT FOR PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING RADICAL PROSTATECTOMY OR RADIATION THERAPY
2004
The ecological sustainability of slash-and-burn agriculture
1995
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
LIMITATIONS IN THE USE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS TO MONITOR PATIENTS AFTER TREATMENT FOR PROSTATE CANCER
2005
Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
1997
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiotherapy: Variables Affecting Patient Outcome
2002
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
2008
THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY
2005
Toward a global estimate of black carbon in residues of vegetation fires representing a sink of atmospheric CO2and a source of O2
1995 StandoutNobel
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
2011
Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer
2002
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Soil erosion and agricultural sustainability
2007 Standout
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
2003 Standout
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
State of the scientific knowledge on properties and genesis of Anthropogenic Dark Earths in Central Amazonia (terra preta de Índio)
2012 Standout
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
2007
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Tropical deforestation and atmospheric carbon dioxide
1991
Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy
2005
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy
2005
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
2005
Biomass Burning in the Tropics: Impact on Atmospheric Chemistry and Biogeochemical Cycles
1990 StandoutScienceNobel
Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
2012
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Consensus statement: Guidelines for PSA following radiation therapy1
1997 Standout
PROSTATE SPECIFIC ANTIGEN DOUBLING TIME SUBSEQUENT TO RADICAL PROSTATECTOMY AS A PROGNOSTICATOR OF OUTCOME FOLLOWING SALVAGE RADIOTHERAPY
2004
Works of Patrick W. McLaughlin being referenced
Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients
1995
Equivalent Biochemical Control and Improved Prostate-Specific Antigen Nadir After Permanent Prostate Seed Implant Brachytherapy Versus High-Dose Three-Dimensional Conformal Radiotherapy and High-Dose Conformal Proton Beam Radiotherapy Boost
2009
Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy
2002
Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy
2000
Optimal placement of radioisotopes for permanent prostate implants.
1996
3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review
2000
Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapy
1993
Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
1994
Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI
2004
Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate
2003
Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy
1997
Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy
2003
Results of 3D conformal radiotherapy in the treatment of localized prostate cancer
1997
Use and uncertainties of mutual information for computed tomography/magnetic resonance (CT/MR) registration post permanent implant of the prostate
2005
Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer
2002
1 Results of 3d conformal radiotherapy in the treatment of 707 patients with localized prostate cancer
1995
World Agriculture and Soil Erosion
1987
Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials
2006
Indium-111–Capromab Pendetide Radioimmunoscintigraphy and Prognosis for Durable Biochemical Response to Salvage Radiation Therapy in Men After Failed Prostatectomy
2003